Baxter’s future vision: focus only on medical products

Baxterplans to focus on rolling out 50 new medical devices worth more than USD 1 billion in annual sales by 2020, with an additional compounded annual sales growth of 4%. If Baxter rolls out these new products, their sales contributions will represent 10% of its total revenues in 2020 and more than 20% by 2025.The company will also embark on acquisitions and collaborations to expand its product portfolio, but none of the acquisitions will be as great as the USD 4 billion Gambro acquisition, which contributed toward structuringits foundation. Baxter presumes to disburse more than 10% of sales on research and development by 2020 for development of life cycle management products and some novel products along with strengthening of its proficiency in drug delivery systems.

Read the full article at FierceMedicalDevices